我国医药产业市场结构优化研究

发布时间：2018-01-01 17:19

本文关键词：我国医药产业市场结构优化研究　出处：《吉林大学》2014年硕士论文　论文类型：学位论文

【摘要】：随着经济发展水平的日益提高和公众对医疗服务需求的不断增长，医药产业在我国的快速崛起已经引起政府、企业和社会的高度重视。虽然我国医药产业取得了巨大的进步，但是与发达国家相比，我国医药产业仍然存在着很多不足，比如：企业数量多、市场集中度过低、没有形成规模经济效益、科研投入不足、科研创新能力不高、产品同质化高、缺乏自身的特色品牌和特色品种。目前，，医药产业正面临市场结构升级与调整的关键时期，但过度竞争以及产品同质化现象日趋严重。所以，医药企业适当的兼并重组，能够提高医药市场集中度，形成规模经济效益，进而促进我国医药产业结构升级及核心竞争能力的提高。此外，政府需要增加科研投入，鼓励医药企业自主创新，加强国际合作，实施知识产权保护，促进我国医药产业的可持续发展。本文试图以产业组织理论为指导，以医药产业市场绩效为切入点分析我国医药市场行为和市场结构的现状，挖掘其深层次原因，同时，借鉴发达国家成功经验，进一步探讨我国医药产业的市场结构优化的相关对策建议。
[Abstract]:With the continuous increase of the level of economic development and increasing public demand for medical services, the pharmaceutical industry has caused the rapid rise of the government in our country, attaches great importance to the enterprise and society. Although China's pharmaceutical industry has made great progress, but compared with developed countries, China's pharmaceutical industry still has many problems, such as: the number of enterprises, the market concentration is too low, not the formation of economies of scale, inadequate investment in scientific research, scientific research and innovation ability is not high, high product homogeneity, the lack of their own brand characteristics and characteristics of cultivars. At present, the pharmaceutical industry is facing a critical period of upgrading and adjustment of the market structure, but the homogenization of the phenomenon of excessive competition and increasingly serious. Therefore, appropriate pharmaceutical enterprises mergers and acquisitions, can improve the pharmaceutical market concentration, scale economic benefit, and promote China's industrial structure upgrading and medicine The core competitive ability. In addition, the government needs to increase investment in scientific research, encourage the pharmaceutical enterprises independent innovation, strengthening international cooperation, the implementation of intellectual property protection, promote the sustainable development of China's pharmaceutical industry. This paper tries to use the theory of industrial organization, market performance in the pharmaceutical industry as the starting point analysis of the current situation of China's pharmaceutical market and market behavior the structure, dig their deep-seated reasons, at the same time, learn from the successful experience of developed countries, to further explore the related countermeasures and suggestions to optimize the market structure of China's pharmaceutical industry.

【学位授予单位】：吉林大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F273.1;F426.72

【参考文献】